|RT35-020||2000 U ( 40U/μl )||Ask for an offer|
|RT35-100||10 000 U ( 40U/μl )||Ask for an offer|
- Product Information
- Products Characteristics
- Protocol & Manual
- Technical Tips
- Quality & Safety
RIBOPROTECT RNase Inhibitor – Maximum RNA protection
RIBOPROTECT Hu RNase Inhibitor is the right choice to overcome the challenges coming with the presence of ubiquitous RNases, commonly found in skin, dust, reagents, and biological samples.
The RIBOPROTECT Hu RNase Inhibitor is a 50 kDa recombinant human placental protein expressed in Escherichia coli. It inhibits ribonuclease (RNase) activity of common eukaryotic enzymes such as RNase A, RNase B, RNase C. by non-covalent binding in a 1:1 ratio. RIBOPROTECT inhibits
RNases by non-covalent binding in a 1:1 ratio with high-affinity protein-protein interaction, forming one of the tightest known biomolecular complexes. Such inhibition effectively helps to maintain the RNA integrity and allows to obtain the appropriate quantity and quality of RNA.
RIBOPROTECT Hu is intended for use in applications where the presence of RNases may cause a substantial hazard in receiving good quality, trustworthy, and reproducible data, e.g. in RNA isolation, cDNA synthesis, RT-PCR, in vitro transcription and translation, or RNase-free monoclonal antibody preparation. RIBOPROTECT Hu shows no activity towards RNase 1, RNase T1, RNase T2, S1 nuclease, and RNase H.
Features and advantages
- Completely inhibits RNase A, B, and C activity
- No influence on the polymerase or reverse transcriptase activity
- Free of DNase and RNase activity
- Retains full stability at 37°C for at least 4 weeks
- Stable up to 58°C and at min. 0.5 – 1 mM DTT concentration ranges
- Active in diverse reaction conditions and in various buffers
- Active over a broad pH range (pH 5.5 – 9.0)
- Compatible with the TRANSCRIPTME Reverse Transcriptase (cat. no. RT32)
- RNA-related molecular diagnostics
- RNA isolation and purification
- cDNA synthesis, RT-PCR, RT-qPCR
- in vitro transcription and translation
- RNase-free monoclonal antibody preparation
One unit is defined as the amount of enzyme required to inhibit the activity of 5 ng RNase A by 50%.
Stability during shipment
RIBOPROTECT displays unaffected activity for 4 weeks when incubated at 37 ̊C. Such a high unchanged activity in challenged temperature conditions is a guarantee of stability during uncontrolled shipment incidents.
RNase Inhibitor – Batch-to-batch consistency
Our customers’ positive feedback is our best proof of reliability. The closeness in activity in the following three RIBOPROTECT batches (purple columns), coming from three different product purifications, shows very high batch-to-batch consistency. The grey column represents activity from a competitive RNase Inhibitor.
The activity (U/μl) of RIBOPROTECT from three separate batches (purple columns) and a competitive RNase Inhibitor (grey column) were tested by BLIRT’s customer.
The efficiency comparison of RIBOPROTECT and competitive RNase Inhibitors
We compared the inhibition efficiency of the RNA degradation by RIBOPROTECT and two broadly used RNase Inhibitors from the top market leaders (marked here as RNase Inhibitor T and RNase Inhibitor P). We incubated 1 μg RNA (kidney cancer cell lines, 786-O) with 5 ng RNase A (BLIRT) at 37°C for 15 min with various RNase Inhibitor concentrations: 20, and 40U in a 20 μl reaction.
RIBOPROTECT displays very high RNA protection (RIN: 9.667±0.240). For the recommended concentration of 40U, no differences were found between RIBOPROTECT and RNase InhibitorP, while RNase Inhibitor T showed lower protection (RIN: 9.678 vs. 8.733, p <0.05). Our results display that both RNase Inhibitor T and P are less efficient than RIBOPROTECT at 20U per 20 μl reaction (p <0.0001).
RNAse Inhibitor efficiency
RIBOPROTECT is the most efficient among all three tested RNase Inhibitors. Its equally high efficiency at 20-40U/20 μl reaction, which BLIRT recommends for most applications proves its high competitiveness among other RNase Inhibitors.
RIBOPROTECT Hu RNase Inhibitor (RT35) - Product Specification
RIBOPROTECT Hu RNase Inhibitor (RT35) - Manual
RIBOPROTECT Hu RNase Inhibitor (RT35) - Flyer
RIBOPROTECT Hu RNase Inhibitor (RT35) - Complete portfolio for RNA workflow
RIBOPROTECT Hu RNase Inhibitor – Troubleshooting
- The optimal final concentration of the RIBOPROTECT Hu in a reaction depends on the level of RNase contamination, the incubation time and the compounds present in the reaction mixture. It falls within a range of 1 – 2 U/μl.
- For a standard reverse transcription reaction, use 1 μl (40 U) of the RIBOPROTECT Hu for a final sample volume of 20 μl.
- For the optimal RIBOPROTECT Hu activity, a final DTT concentration of 0.5 – 1 mM is essential.
- During assembly of a reaction, RIBOPROTECT Hu should be added before other components that are possible sources of RNase contamination.
- Using RIBOPROTECT Hu does not exclude RNase H treatment after amplification of the first strand cDNA.
20 mM HEPES-KOH (pH 7.6); 50 mM KCl; 8 mM reducing agent; 50% (v/v) glycerol
Store at -20°C in a freezer without a defrost cycle.
The absence of Endonuclease, Exonuclease, RNase and latent RNase activities has been confirmed using the relevant procedures. The purity is >90% as judged by SDS-polyacrylamide gels.
RIBOPROTECT Hu RNase Inhibitor (RT35) - MSDS
RIBOPROTECT Hu RNase Inhibitor (RT35) - CoA
In Situ Sequencing: A High-Throughput, Multi-Targeted Gene Expression Profiling Technique for Cell Typing in Tissue Sections
Authors Markus M. Hilscher, Daniel Gyllborg, Chika Yokota, Mats Nilsson Products RIBOPROTECT Hu RNase Inhibitor (RT35), RNase H (RT34), T4 DNA Ligase (EN11), TRANSCRIPTME Reverse Transcriptase (RT32), Tth DNA Ligase (EN13) Year 2020 Source In Situ Hybridization Protocols. Methods in Molecular Biology, vol 2148
Hybridization-based in situ sequencing (HybISS) for spatially resolved transcriptomics in human and mouse brain tissue
Authors Daniel Gyllborg, Christoffer Mattsson Langseth, Xiaoyan Qian, Eunkyoung Choi, Sergio Marco Salas, Markus M Hilscher, Ed S Lein, Mats Nilsson Products phi29 Polymerase (EN20) – Discontinued, RIBOPROTECT Hu RNase Inhibitor (RT35), TRANSCRIPTME Reverse Transcriptase (RT32), Tth DNA Ligase (EN13) Year 2020 Source Nucleic Acids Research
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment
Authors Bac Viet Le, Paulina Podszywalow-Bartnicka, Silvia Maifrede, Katherine Sullivan-Reed, Margaret Nieborowska-Skorska, Konstantin Golovine, Juo-Chin Yao, Reza Nejati, Kathy Q. Cai, Lisa Beatrice Caruso, Julian Swatler, Michal Dabrowski, Zhaorui Lian, Peter Valent, Elisabeth M. Paietta, Ross L. Levine, Hugo F. Fernandez, Martin S. Tallman, Mark R. Litzow, Jian Huang, Grant A. Challen, Daniel Link, Italo Tempera, Mariusz A. Wasik, Katarzyna Piwocka, Tomasz Skorski Products RIBOPROTECT Hu RNase Inhibitor (RT35) Year 2020 Source Cell Reports Volume 33, Issue 1